Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | CA9 | Q16790 | 3/20 | 0.39 |
| ▸ | IDH2 | P48735 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Altretamine SCHEMBL4448907 | 1.00 | LMNA (0.61) | LMNACYP1A2THRBBLMCREBBP | |
| Pentamethyl Melamine SCHEMBL15346326 | 0.97 | LMNA (0.58) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL1033226 | 0.94 | CYP1A2 (0.53) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL13599448 | 0.85 | PDE4A (0.46) | LMNACYP1A2THRBBLMCREBBP | |
| Altretamine SCHEMBL1978783 | 0.84 | LMNA (0.48) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL60190 | 0.84 | LMNA (0.42) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL11556026 | 0.84 | PDE4A (0.48) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL18737196 | 0.84 | PDE4A (0.45) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL3234910 | 0.83 | LMNA (0.42) | LMNACYP1A2THRBBLMCREBBP | |
| SCHEMBL9988581 | 0.80 | POLB (0.50) | LMNACYP1A2THRBBLMCREBBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3120 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250326859-A1 | ANTI-CANCER ANTIBODIES, COMBINATION THERAPIES, AND USES THEREOF | PREC BIOLOGICS INC (US) | 2025-10-23 | — | — | US | claimed |
| US-20250275946-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2025-09-04 | — | — | US | claimed |
| WO-2025064690-A1 | HIGH AFFINITY ANTIBODIES RECOGNIZING CORE 2 O-GLYCANS OF VARIANT MUC5AC ANTIGEN, COMPOSITIONS CONTAINING AND USES THEREOF | PRECISION BIOLOGICS, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| CN-110357825-B | Improved co-production of pentahydroxy and hexamethylol melamine | 重庆建峰浩康化工有限公司 | 2023-01-24 | — | — | CN | claimed |
| US-11560352-B2 | P62-ZZ small molecule modulators | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2023-01-24 | — | — | US | claimed |
| WO-2022169634-A9 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2022-09-22 | — | — | WO | claimed |
| WO-2022169634-A1 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | UNM RAINFOREST INNOVATIONS (US) | 2022-08-11 | — | — | WO | claimed |
| US-11279768-B1 | Anti-cancer antibodies, combination therapies, and uses thereof | PRECISION BIOLOGICS, INC. (US) | 2022-03-22 | — | — | US | claimed |
| US-11058687-B2 | Human papilloma virus as predictor of cancer prognosis | FOUNDATION MEDICINE, INC. (US) | 2021-07-13 | — | — | US | claimed |
| CN-107540803-B | Method for synthesizing butylated amino resin by using pentamethyl melamine | 重庆建峰浩康化工有限公司 | 2021-03-23 | — | — | CN | claimed |
| EP-1206252-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING POLYMERS | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2002-05-22 | — | — | EP | claimed |
| EP-1206251-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING NANOPARTICLES | BIOTECH AUSTRALIA PTY. LIMITED (AU) | 2002-05-22 | — | — | EP | claimed |
| EP-0668782-B1 | COMBINATION OF ANTINEOPLASTIC AGENT AND ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER | UNIV TEMPLE (US) | 2001-04-11 | — | — | EP | claimed |
| WO-2000074721-A1 | VITAMIN DIRECTED DUAL TARGETING THERAPY | BIOTECH AUSTRALIA PTY LIMITED (AU) | 2000-12-14 | — | — | WO | claimed |
| WO-2000066091-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING POLYMERS | BIOTECH AUSTRALIA PTY LIMITED (AU) | 2000-11-09 | — | — | WO | claimed |
| WO-2000066090-A1 | AMPLIFICATION OF FOLATE-MEDIATED TARGETING TO TUMOR CELLS USING NANOPARTICLES | BIOTECH AUSTRALIA PTY LIMITED (AU) | 2000-11-09 | — | — | WO | claimed |
| WO-1997032589-A1 | COMBINATIONS FOR TREATMENT OF PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 1997-09-12 | — | — | WO | claimed |
| WO-1997032604-A1 | ANTIPROLIFERATIVE COMBINATIONS, CONTAINING RAF-TARGETED OLIGONUCLEOTIDES AND CHEMOTHERAPEUTIC COMPOUNDS | NOVARTIS AG (CH) | 1997-09-12 | — | — | WO | claimed |
| EP-0668782-A1 | COMBINATION OF ANTINEOPLASTIC AGENT AND ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1995-08-30 | — | — | EP | claimed |
| WO-1994008625-A1 | COMBINATION OF ANTINEOPLASTIC AGENT AND ANTISENSE OLIGONUCLEOTIDES FOR TREATMENT OF CANCER | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1994-04-28 | — | — | WO | claimed |